title: Harnessing the therapeutic potential of host antiviral restriction factors that target HIV.
authors: Richard D
authors: RD
authors: Sloan
authors: Mark A
authors: MA
authors: Wainberg
mesh_terms: D000071480:APOBEC-3G Deaminase; D000818:Animals; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D015703:Antigens, CD / Q000008:administration & dosage / Q000502:physiology*; D000090103:Antiviral Restriction Factors; D002352:Carrier Proteins / Q000008:administration & dosage / Q000502:physiology*; D003564:Cytidine Deaminase / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000502:physiology*; D058851:GPI-Linked Proteins / Q000008:administration & dosage / Q000502:physiology; D016346:Gene Products, vif / Q000378:metabolism / Q000502:physiology; D018390:Gene Targeting / Q000379:methods; D015658:HIV Infections / Q000235:genetics / Q000628:therapy* / Q000821:virology; D015497:HIV-1 / Q000235:genetics* / Q000276:immunology; D054884:Host-Pathogen Interactions / Q000235:genetics / Q000276:immunology; D006801:Humans; D016296:Mutagenesis; D000070584:Tripartite Motif Proteins; D044767:Ubiquitin-Protein Ligases; D014779:Virus Replication / Q000235:genetics / Q000276:immunology; D000074010:Bone Marrow Stromal Antigen 2
chemical_list: D000071480:APOBEC-3G Deaminase; D019380:Anti-HIV Agents; D015703:Antigens, CD; D000090103:Antiviral Restriction Factors; D002352:Carrier Proteins; D003564:Cytidine Deaminase; D058851:GPI-Linked Proteins; D016346:Gene Products, vif; D000070584:Tripartite Motif Proteins; D044767:Ubiquitin-Protein Ligases; C094572:BST2 protein, human; D000074010:Bone Marrow Stromal Antigen 2; C477346:TRIM5 protein, human; C464924:APOBEC3G protein, human